Early abortion with 800 μg of misoprostol by the vaginal route

Contraception

Volumn 59, Issue 4, 1999, Pages 219-225

  Carbonell Esteve, J L L ^a   Varela, L ^b   Velazco, A ^a   Tanda, R ^b   Cabezas, E ^b   Sanchez C ^b  

^a Family Planning Center   (Spain)

^b Hosp Docente Gineco O   (Cuba)

Author keywords

Misoprostol; Pregnancy termination

Indexed keywords

MISOPROSTOL;

ADULT; ARTICLE; CHILL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; FEMALE; FEVER; HEADACHE; HUMAN; INTRAVAGINAL DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; NAUSEA; PELVIS PAIN SYNDROME; PREGNANCY TERMINATION; QUESTIONNAIRE; RASH; VAGINA BLEEDING; VERTIGO;

ABORTIFACIENT AGENTS, NONSTEROIDAL; ABORTION, INDUCED; ADMINISTRATION, INTRAVAGINAL; ADOLESCENT; ADULT; FEMALE; GESTATIONAL AGE; HUMANS; KINETICS; MIDDLE AGED; MISOPROSTOL; PAIN; PREGNANCY; TREATMENT OUTCOME; UTERINE HEMORRHAGE;

EID: 0032798784     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0010-7824(99)00032-3     Document Type: Article

References (16)

1. Norman J.E., Thong K.J., Baird D.T. Uterine contractility and induction of abortion in early pregnancy by misoprostol and mifepristone. Lancet. 338:1991;1233-1236.
2. Peyron R., Aubeny E., Targosz V., et al. Early termination of pregnancy with mifepristone (RU486) and the orally active prostaglandin misoprostol. N Engl J Med. 328:1993;1509-1513.
3. Creinin M.D., Vittinghoff E., Keder L., Darney P.D., Tiller G. Methotrexate and misoprostol for early abortion a multicenter trial. I. Safety and efficacy . Contraception. 53:1996;321-327.
4. Creinin M.D. Oral methotrexate and vaginal misoprostol for early abortion. Contraception. 54:1996;15-18.
5. Carbonell J.L.L., Varela L., Velazco A., Cabezas E., Fernández C., Sánchez C. Oral methotrexate and vaginal misoprostol for early abortion. Contraception. 57:1997;83-88.
6. Carbonell J.L.L., Varela L., Velazco A., Cabezas E., Fernández C., Sánchez C. 25 or 50 Mg of oral methotrexate followed by vaginal misoprostol seven days later for early abortion. Obstet Gynecol Invest. 153:1999;1410-1418.
7. Mishell D.R. Jr, Jain J.K., Byrne J.D., Lacarra M.D.C. A medical method of early pregnancy termination using tamoxifen and misoprostol. Contraception. 58:1998;1-6.
8. Rabe T., Basse H., Thuro H., Kiesel L., Runnebaum B. Wirkung des PGE1 methylanalogons misoprostol auf den schwangeren uterus im ersten trimester (Effect of the PEG1 methyl analog misoprostol on the pregnant uterus in the first trimester). Geburtshilfe Frauenheilkd. 47:1987;324-331.
9. Koopersmith T.B., Mishell D.R. Jr. The use of misoprostol for termination of early pregnancy. Contraception. 53:1996;237-242.
10. Bugalho A., Faúndes A., Jamisse L., Usfá M., Bique M.E. Evaluation of the effectiveness of vaginal misoprostol to induce first trimester abortion. Contraception. 53:1996;243-246.
11. Carbonell J.L.L., Varela L., Velazco A., Fernandez C. The use of misoprostol for termination of early pregnancy. Contraception. 55:1997;165-168.
12. Carbonell J.L.L., Varela L., Velazco A., Fernández C., Sánchez C. The use of misoprostol for abortion at ≤9 weeks' gestation. Eur J Contracep Reprod Health Care. 2:1997;181-185.
13. Carbonell J.L.L., Varela L., Velazco A., Cabezas E., Tanda R., Sánchez C. Vaginal misoprostol for late first trimester abortion. Contraception. 57:1998;329-333.
14. Carbonell J.L.L., Varela L., Velazco A., Tanda R., Sánchez C. Vaginal misoprostol for early second trimester abortion. Eur J Contracep Reprod Health Care. 3:1998;93-98.
15. Hellman L.M., Kobayashi M., Fillisti L., Lavenhar M., Cromb E. Growth and development of the human fetus prior to the twentieth week of gestation. Am J Obstet Gynecol. 103:1969;789-798.
16. Winikoff B., Ellertson C., Clark S. Analysis of failure in medical abortion. Contraception. 54:1996;323-327.